Benzinga - by Lisa Levin, Benzinga Editor.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
- Piper Sandler increased Alteryx, Inc. (NYSE: AYX) price target from $30 to $32. Piper Sandler analyst Brent Bracelin maintained an Underweight rating. Alteryx shares gained 17% to $35.50 in pre-market trading. See how other analysts view this stock.
- Keybanc cut the price target for IAC Inc. (NASDAQ: IAC) from $81 to $72. Keybanc analyst Justin Patterson maintained an Overweight rating. IAC shares fell 1.1% to close at $44.29 on Monday. See how other analysts view this stock.
- DA Davidson raised Appian Corporation (NASDAQ: APPN) price target from $50 to $55. DA Davidson analyst Gil Luria upgraded the stock from Neutral to Buy. Appian shares fell 6.3% to close at $37.40 on Monday. See how other analysts view this stock.
- Morgan Stanley cut the price target for RE/MAX Holdings, Inc. (NYSE: RMAX) from $19.5 to $9. Morgan Stanley analyst Richard Hill downgraded the stock from Equal-Weight to Underweight. RE/MAX shares fell 7.3% to close at $10.80 on Monday. See how other analysts view this stock.
- Stifel slashed the price target for Mirati Therapeutics, Inc. (NASDAQ: MRTX) from $83 to $59. Stifel analyst Benjamin Burnett downgraded the stock from Buy to Hold. Mirati Therapeutics shares rose 0.4% to $56.51 in pre-market trading. See how other analysts view this stock.
- Needham cut Alphatec Holdings, Inc. (NASDAQ: ATEC) price target from $20 to $16. Needham analyst David Saxon maintained a Buy rating. Alphatec shares fell 0.5% to close at $10.31 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. cut Alto Ingredients, Inc. (NASDAQ: ALTO) price target from $7 to $5.5. HC Wainwright & Co. analyst Amit Dayal maintained a Buy rating. Alto Ingredients shares fell 50.9% to $2.41 in pre-market trading. See how other analysts view this stock.
- Needham increased the price target for EverQuote, Inc. (NASDAQ: EVER) from $8 to $10. Needham analyst Mayank Tandon maintained a Buy rating. EverQuote shares fell 5.6% to close at $7.44 on Monday. See how other analysts view this stock.
- Wedbush increased Ventas, Inc. (NYSE: VTR) price target from $44 to $51. Wedbush analyst Richard Anderson upgraded the stock from Neutral to Outperform. Ventas shares gained 0.5% to close at $44.28 on Monday. See how other analysts view this stock.
- Needham lowered Compass, Inc. (NYSE: COMP) price target from $4 to $3. Needham analyst Bernie McTernan maintained a Buy rating. Compass shares gained 4.3% to $2.21 in pre-market trading. See how other analysts view this stock.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.